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Abstract
The functional basis of genetic robustness, the ability of organisms to suppress the effects of
mutations, remains incompletely understood. We exposed a set of 15 strains of Saccharomy-
ces cerevisiae form diverse environments to increasing doses of the chemical mutagen EMS.
The number of the resulting random mutations was similar for all tested strains. However,
there were differences in immediate mortality after the mutagenic treatment and in defective
growth of survivors. An analysis of gene expression revealed that immediate mortality was
lowest in strains with lowest expression of transmembrane proteins, which are rich in thiol
groups and thus vulnerable to EMS. A signal of genuine genetic robustness was detected for
the other trait, the ability to grow well despite bearing non-lethal mutations. Increased toler-
ance of such mutations correlated with high expression of genes responsible for the oxidative
energy metabolism, suggesting that the negative effect of mutations can be buffered if enough
energy is available. We confirmed this finding in three additional tests of the ability to grow on
(i) fermentable or non-fermentable sources of carbon, (ii) under chemical inhibition of the elec-
tron transport chain and (iii) during overexpression of its key component, cytochrome c. Our
results add the capacity to generate energy as a general mechanism of genetic robustness.
Author summary
The ability to suppress phenotypic effects of mutations is termed genetic robustness. Its
functional basis and evolutionary origin remain insufficiently understood despite decades of
research. In fact, it is still largely untested whether genetic robustness is a trait of substantial,
within-species variation. We used a model organism, Saccharomyces cerevisiae, to study
both phenotypic signs and functional underpinnings of genetic robustness. We introduced
random mutations into a set of well-characterized yeast strain. There was considerable vari-
ation in the growth rate among clones recovered after mutagenesis, which is an indication
of genetic robustness. Using available data on gene expression for our strains, we found that
genetic robustness was strongest among strains with enhanced expression of genes related
to the energy metabolism. We reasoned that, regardless of the specific mutations, the
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capacity to generate metabolic energy may be a general underlying mechanism for buffering
the effects of random mutations across the genome. We confirmed this hypothesis in further
experiments in which we showed that genetic robustness decreases when the energy metab-
olism is compromised and increases when it is boosted.
Introduction
Robustness is the ability of an organism to perform its functions when faced with genetic
or environmental perturbations [1]. Robustness against mutations is particularly intrigu-
ing. Numerous studies have found that a surprisingly large proportion of gene-inactivat-
ing mutations have little consequence for fitness, both in microorganisms and metazoans
[2]. In the budding yeast, knockouts of single genes showed that only about one fifth of
them are essential for growth while two fifths have effects undetectable under standard
laboratory conditions [3, 4]. The simplest explanations point to functional redundancy as
the source of genetic robustness. However, even in the budding yeast, a species that
underwent a whole genome duplication event early in its history [5], the ubiquity of dis-
pensable genes can be only partly explained by the presence of their duplicates [6–8].
Other hypotheses say that genetic robustness may also be a non-selected byproduct of
other traits [9–12] or a feature evolved in congruence with environmental robustness [13–
15]. It has been also suggested that genetic robustness can be an autonomous trait that
evolved not only to help in current functioning of organisms but also to facilitate their
evolvability [10, 16–18].
Robustness can be rooted in many processes and features [19, 20]. However, some ele-
ments of the eukaryotic cell are more likely than others to be essential in the face of pertur-
bation. Examples include enzymes involved in mRNA processing, protein quality control
and chaperoning, protein modifications and chromatin remodeling [21]. The best known
among them are molecular chaperones, a class of proteins engaged in primary folding and
refolding of destabilized proteins [18, 22, 23]. Indeed, overexpression of the GroEL chaper-
one is likely to mitigate the effects of mutational load accumulated under genetic drift in
bacteria [24, 25]. However, chaperones also act as examiners of proteins, often triggering
their degradation and depletion [26, 27], and therefore their overall impact on masking or
exposing mutations has to be carefully examined [28, 29]. Another group of molecules puta-
tively involved in robustness are chromatin modulators [30, 31]. They may help to hide
genetic variation by condensing chromatin in some regions of the genome, to later release
this variation when conditions change [32].
We asked whether a set of diverse strains of the budding yeast Saccharomyces cerevisiae
exhibit differences in their ability to tolerate random mutations. These strains come from a
collection of wild and domesticated strains that has been analyzed extensively [33–40]. In par-
ticular, complete genome sequences are available, as well as transcript abundances determined
under controlled laboratory conditions [34]. We mutagenized a subset of 15 of these strains
with increasing doses of ethyl methanesulfonate (EMS). The treatment resulted in similar
numbers of mutations, but the phenotypic response to mutagenesis varied considerably, indi-
cating variation in genetic robustness. Analysis of mRNA expression data showed that there
was a strong correlation between genetic robustness and the ability to generate metabolic
energy. This finding was then confirmed experimentally in three different tests: a comparison
of growth on fermentable and non-fermentable carbon sources, effects of chemical inhibition
of respiration and effects of overexpression of an element of the electron transport chain.
Genetic robustness in yeast
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Results
Mutation rate at the URA3 locus is uniform across all strains
Strains used in this study derive from a well-characterized collection of wild and domesticated
strains of S. saccharomyces (Liti et al. 2009). They were originally deleted for URA3 [41]. We
re-introduced a functional copy of this gene, so that it could be used as a reporter of inactivat-
ing mutations. Clones carrying such mutations are able to grow on media containing 5-fluor-
oorotic acid (5-FOA). We first asked whether individual strains acquire mutations at similar
rates when treated with EMS. The strains were exposed to a range of EMS doses up to ones
typically used in mutagenesis experiments (30 or 40 μl/ml). EMS is known to introduce mainly
single base-pair substitutions [42], a class of mutations known to prevail also among spontane-
ous mutations inactivating the target gene, URA3 [43]. Fig 1A shows that the number of
mutants increased significantly with the increasing dose of mutagen (F = 673.5; dfs = 4, 74;
p< 0.0001). Crucially, there were no differences between strains in the number of mutants
(F = 1.4; dfs = 14, 74; p = 0.162). We, therefore, could average the frequencies of mutations
across strains and fit a quadratic function, one for all strains, describing the relationship
between the dose of EMS and the number of mutations it introduced (Fig 1B). (Data needed
for this analysis and graph, as well as all other analyses and graphs, are shown in S1 Table in
the Supporting Information).
Mortality is explained by the toxic effect of EMS
These results mean that the frequency of mutations at the molecular level increased with an
increasing dose of EMS at a similar rate in all compared strains. We then asked whether the
same was true for the rate of mortality. As expected, the number of survivors differed between
doses of the mutagen (F = 913.2; df = 9; 74; p< 0.0001). Unlike the rate of mutation to Ura¯,
the rate of mortality differed between individual strains (F = 9.62; df = 14, 74; p< 0.001). To
Fig 1. Relationship between EMS dosage and numbers of mutations introduced. (A) Number of URA3
mutations per strain per concentration estimated from c.f.u. counts on medium containing 5-FOA. The
increasing sizes of dots represent increasing doses of mutagen, from 0 to 30 μl/ml. (B) The relation between
the dose of EMS applied and the mutant count approximated by a polynomial function. The function is then
used to replace the EMS dose by the “relative mutation load” measuring the increase in mutation number
relative to untreated cells. (There are seven EMS doses at B and only five in A because for two doses, 2 and
40 μl/ml, there were lacking replicas and they were excluded from ANOVA testing for the strain and dose
effects).
https://doi.org/10.1371/journal.pgen.1006768.g001
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further test for differences between strains, we fitted the data to survival curves (the Weibull
survivor function performed best when compared with log-logistic and log-normal models)
and calculated for individual strains the EMS dose which was lethal for 50% of exposed cells
(LD50). Fig 2 shows that the LD50 of the most sensitive strains was about twice as low as that of
the most resistant ones.
EMS is not only a mutagen, but also a toxin that can kill yeast cells without introducing
lethal mutations [44]. To test whether the observed mortality can be linked to the toxic activity
of EMS or to the rise of lethal mutation, we turned to functional analyses. We correlated the
LD50 values with the abundance of 6207 mRNA transcripts reported for the same strains in a
former study in which growth conditions were determined by low content of glucose and lim-
iting concentration of phosphorous [34]. (We mimicked these conditions in our study). We
then asked which Gene Ontology categories are overrepresented among transcripts best corre-
lated (either positively or negatively) with LD50. This was done by calculating a Spearman’s
correlation coefficient for each gene and ranking the list of all genes according to either
decreasing or increasing coefficients followed by an analysis of overrepresentation of high
ranks within GO categories [45]. After trimming the most overlapping gene categories [46],
the results can be summarized in a way shown in Fig 3. Two conclusions emerged from these
analyses. First, survival improved (LD50 values were high) with increasing expression of genes
responsible for rRNA processing and biogenesis. Second, survival decreased (LD50 values were
low) with increasing expression of genes coding for membrane-bound permeases and trans-
porter proteins. The latter finding is a hint that high mortality following mutagenesis resulted
from high susceptibility of the strains’ proteomes to EMS rather than from the rise of different
numbers of lethal mutations in their genomes.
Robustness of growth correlates positively with the expression of
aerobic respiration genes
To test for genetic robustness against non-lethal mutations, here understood as the ability to
retain a relatively high growth rate, we measured the maximum growth rate (MGR) of clones
picked at random from survivors of every strain at every dose of EMS. MGR was measured in
medium with a reduced level of glucose (0.5%) and limiting level of phosphorus identical to
Fig 2. Survival immediately after EMS treatment. (A) Example of a single strain’s survival curve. A Weibull curve is fitted to
estimate the LD50 (lethal dose killing 50% of population). Each point is the mean of two replicates. (B) LD50 values with 95%
confidence limits of individual strains ranked according to EMS sensitivity (low sensitivity requires a high dose of EMS for LD50).
https://doi.org/10.1371/journal.pgen.1006768.g002
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that used in the above mentioned gene expression study [34]. The authors of that study used
chemostats running at a set dilution rate to minimize the effects of growth rate variation on
gene expression. We used batch cultures at 23˚C to obtain an average growth rate possibly
closest to that realized in chemostats, without inducing cold stress [47]. Fig 4A shows relative
growth rates of individual isolates declining as intensity of mutagenesis increased. The inten-
sity of mutagenesis is expressed as a “relative mutation load”, which was calculated by regress-
ing Ura¯ mutant counts on EMS doses, from 0 to 40 μl/ml. Therefore, the relative mutation
load accounts for the relation between the concentration of EMS and the number of mutations
incurred (see legend of Fig 1B). A simple measure of genetic robustness is the mean decrease
in the maximum growth rate across the whole gradient of mutagenesis, ΔM. The so-called
Bateman-Mukai technique [48] takes into account not only an increase in the mean but also
variation and yields U, an estimated minimal number of phenotypically distinguishable muta-
tions (negative growth effects). Fig 4B and 4C show that both ΔM and U vary extensively
among strains and, as expected, are negatively correlated. In the following analyses, we use U
as it is based both on the means and variances of the phenotypes of mutated strains and more
appropriate to ask how often a damage is visible. (U can be interpreted as a proportion of
molecular mutations with an effect on growth.) Returning to the question of the double effect
of EMS, toxic and mutagenic, we note that mortality and growth impairment are not corre-
lated (Pearsons’s correlation coefficients between LD50 and U30, r = 0.028, n = 15), p>0.05).
Because the two traits react differently to EMS, they should depend on different cellular
processes.
To test this assertion, we correlated U with the mRNA expression datasets in the same way
as we previously did for LD50. The statistically strongest and functionally least overlapping
results of the mRNA analysis are shown in Fig 5. The most remarkable finding was that the
robustness was highest when expression of genes involved production of ATP on the electron
transport chain was highest. When the analyses were restricted to no more than 30 μl/ml of
Fig 3. Test for functional determinants of mortality immediately after EMS treatment. Enhanced expression of mRNA transcripts
was correlated with either decreased or increased mortality (increased or decreased LD50, respectively) across the 15 strains. Only
Gene Ontology categories that overlap less than 50% and have p-values lower than 0.001 are shown. Circles that are larger and more
shifted to the left indicate larger numbers of genes involved and stronger statistical signals, respectively. Categories related to either
RNA metabolism or cytoplasmic ribosome assembly (left) or trans-membrane flux (right) are in shown black.
https://doi.org/10.1371/journal.pgen.1006768.g003
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EMS, a strong signal of an opposite relation was detected: robustness decreases when the mito-
chondrial translation intensifies (Fig 5B). In the discussion section, we develop an argument
that the high efficiency of oxidative phosphorylation and low of mitochondrial translation are
linked and beneficial for genetic robustness.
Experimental verification of the dependence of genetic robustness on
metabolic energy supply
To verify whether robustness can be explained by energy metabolism, we performed three
independent tests: growth on different carbon sources, growth after chemical inhibition of oxi-
dative phosphorylation and growth after boosting oxidative phosphorylation through genetic
manipulation. In the first test, we grew the collection of non-mutagenized strains on different
carbon sources (23˚C, P-limited medium with addition of either 0.5% glucose, 2% glucose or
3% ethanol). Fig 6 shows that strains that excelled in resisting the burden of mutations (lowest
U in Fig 4C) were not among those growing well on 0.5% glucose (the medium used in the
main experiment), nor on high glucose. It appears that mutational robustness did not result
from the ability to adjust metabolism specifically to the environment used. Rather, it was cor-
related with the ability to grow well on 3% ethanol, in line with the results of the GO analysis.
Fig 4. Genetic robustness estimated as the decline of the maximum growth rate (MGR) along increasing mutation load
resulting from an earlier EMS treatment. (A) An example of a single strain’s declining MGR values (normalized by the MGR of
untreated cells) related to the increasing relative mutation load (defined in Fig 1B). The slope of the line, ΔM, is the rate of fitness
(MGR) decline with increasing number of mutations. (B) ΔM values with 95% confidence limits of individual strains (least robust
have highest negative ΔM values). (C) U, the minimal number of mutations (with effect on MGR) obtained from the Bateman-
Mukai equation. U values are ranked according to increasing robustness (least robust strains have highest U). The ranks used for
U were adopted also for ΔM to show a negative relationship between the two parameters.
https://doi.org/10.1371/journal.pgen.1006768.g004
Genetic robustness in yeast
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In the second test, we sought to directly manipulate the profile of energy metabolism within
one strain instead of using multiple strains differing in this respect. We treated a standard lab-
oratory strain, BY4742 MATα, with 30 μl/ml doses of EMS in the same way as in the experi-
ments described above. We then exposed a random sample of the resulting mutants to sodium
azide (NaN3), which inhibits specifically the electron transport chain by binding to the cyto-
chrome c oxidase complex. In this test, we applied the same temperature and medium, but we
checked for growth on agar surface in a standard spotting assay. (We were unable to find a suf-
ficiently long phase of stable exponential growth in liquid cultures with NaN3 added). We
expected that moderate doses of NaN3 would hamper growth of mutagenized cells significantly
Fig 5. Test for functional determinants of growth of mutagenized strains (indicating robustness against non-lethal mutations).
Enhanced expression of mRNA transcripts was correlated with either increased or decreased robustness (decreased or increased U,
respectively). Upper panels refer to analyses done for the EMS range from 0 to 40 μl/ml (as in all other analyses reported here); lower
panels refer to the EMS range from 0 to 30 μl/ml (thus relates to robustness in the face of lower mutation loads; note that results obtained
with both ranges are generally similar). Only Gene Ontology categories which overlap by less than 50% and have p-values lower than
0.001 are shown. Circles that are larger and more shifted to the left indicate larger numbers of genes involved and stronger statistical
signals, respectively. Categories related either to oxidative phosphorylation (right) or mitochondrial translation (left) are shown in black.
https://doi.org/10.1371/journal.pgen.1006768.g005
Genetic robustness in yeast
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stronger than that of non-mutagenized cells. Indeed, Fig 7 shows that mutants were often
affected more than the non-mutagenized control.
In the third test, we wanted to boost functioning of the oxidative phosphorylation pathway.
The electron transport chain comprises several multi-protein complexes, and several genes
would have to be overexpressed to elevate the activity of just one of them. The cytochrome c is
outstanding in this respect, being composed of a heme group and a single polypeptide (Cyc1
in yeast). We transformed BY4742 with a multicopy plasmid carrying the CYC1 gene under
control of the TEF promoter and also a control plasmid, one of the same backbone and trophic
markers, but with no gene overexpressed (see Materials). Fig 8A shows that overexpression of
CYC1 increased the cellular level of cytochrome c, especially in its reduced form, indicating
that this step in the transportation of electrons was successfully upregulated.
We then obtained a large number of BY mutants (with 30 μl/ml of EMS). We transformed
each of them with each of the two plasmids and measured MGR in the same way as in our pre-
vious assays. Results are presented in Fig 8B. There were 311 mutants that were successfully
transformed with both plasmids, and each transformant was assayed twice. MGR differed
greatly between mutants (F = 25.97, dfs = 310, 932; p<<0.0001). Most importantly for our
hypothesis, there was a statistically significant difference in the mean MGR of mutants bearing
either the pCYC1 or control plasmid (respective means 0.1699 and 0.1668; F = 12.833; dfs = 1,
Fig 6. Robustness of the 15 strains in relation to performance on different energy sources (estimated as the maximum growth
rate, MGR). Low values of U indicate high genetic robustness estimated under standard conditions for this experiment (0.5% glucose).
https://doi.org/10.1371/journal.pgen.1006768.g006
Fig 7. The impact of inhibition of the electron chain on growth. A non-mutated reference strain and a random sample of 12 EMS-
induced mutants (all of the BY4742 background) were grown in the absence or presence of 0.2 mM sodium azide, which inhibits
cytochrome c. Except for agar, growth conditions were the same as in the genetic robustness assays (see Fig 4).
https://doi.org/10.1371/journal.pgen.1006768.g007
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932; p = 3.58×10−4). To perform analogous tests for the non-mutated reference strain, we
paired at random 66 replicate wild-type clones overexpressing pCYC1 with 66 replicates
expressing the control plasmid (each measured twice). There was some variation among pairs
created in this way (F = 1.512; dfs = 65, 197; p = 1.63×10−2), which was likely introduced by
assay block effects. Crucially, there was no difference between wild-type clones with pCYC1
Fig 8. Effects of the cytochrome c coding gene (CYC1) overexpression. (A) Absorption spectra of BY4742 when overexpressing CYC1
(green, 6 replicates) or not (blue, 6 replicates). Relative absorption was calculated by subtracting the absorption at 640 nm and dividing by the
absorption at 580 nm within each replicate. The cellular level of the cytochrome c in its reduced form is indicated by the peak at 550 nm. The
downstream enzyme (cytochrome c oxidase) peaks at 600 nm. (B) MGR of BY4742 transformed with either pCYC1 or control plasmid (pControl,
see Methods for details). Black circles denote replicate estimates for a non-mutagenized reference strain. Red circles denote individual mutated
strains. Means of two replicates are used as coordinates. Results of ANOVA are in the main text. (C) Density plots of log pCYC1/pControl ratios of
MGR for mutant (red) and reference (gray) strains. Statistics refer to results of a Kolgomorov-Smirnov test.
https://doi.org/10.1371/journal.pgen.1006768.g008
Genetic robustness in yeast
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and control plasmid within the reference strain (respective means 0.2042 and 0.2034;
F = 0.036; dfs = 1, 197; p = 0.849). The average advantage of mutants bearing pCYC1 over
those with the control plasmid did not result from strong but relatively few effects. Positive
effects, measured as log(MGRpCYC1/MGRpControl) were widespread leading to a statistically sig-
nificant shift in modal region of frequency distribution (Fig 8C). In sum, all three of our tests
consistently support the notion that efficient energy metabolism yields genetic robustness in
the 15 yeast strains we examined.
Discussion
We studied genetic robustness in yeast by measuring the performance of a collection of diverse
strains subject to mutagenesis. We found that mutagenesis resulted in considerably different
phenotypic responses in different strains. There were differences in mortality and in the sever-
ity of growth defects among survivors. The two effects were statistically uncorrelated and asso-
ciated with different patterns of gene expression. High mortality (high susceptibility to the
toxin, low LD50) correlated with high expression of genes coding for membrane-bound trans-
porter proteins and permeases. EMS is known to bind the thiol groups of proteins [44]. These
groups are ubiquitous in the proteins residing in the cell membrane that are exposed to the
external environment. There was also a strong correlation between low sensitivity to the toxin
(high LD50 values) and high expression of genes responsible for rRNA processing and protein
synthesis. This result is also understandable. To enable recovery after EMS treatment, cells
were transferred to standard medium with a high concentration of glucose, which is a strong
signal to start growth. Strains that were able to rapidly activate the translational machinery
after mutagenesis had therefore a better chance of escaping the toxic effect of EMS-induced
protein damage [49, 50]. We conclude that mortality appeared to result from the toxicity of
EMS rather than from the introduced mutations.
The second of the studied traits, the ability to grow well despite carrying random mutations,
is an evident sign of genetic robustness. Growth rates correlated positively with high expres-
sion of genes coding for oxidative phosphorylation and negatively with high expression of
genes coding for mitochondrial ribosomes (Fig 5). Both oxidative phosphorylation and mito-
chondrial translation occur inside mitochondria. In our experiment, as in the former gene
expression study, glucose was relatively low and phosphorous was limiting [34]. It has been
shown that, for growth rates similar to those estimated here, raising the fraction of energy
acquired through oxidation makes the metabolism substantially more efficient [51]. The
observed requirement for low expression of the mitochondrial ribosome proteins fits this con-
jecture. In budding yeast, unlike other organisms, growth rate remains high even if the expres-
sion of mitochondrial ribosome proteins declines [52]. More importantly, there is only one
RNA polymerase for all genes residing on the mitochondrial chromosome, including elements
of the oxidative phosphorylation complexes and mitochondrial ribosomes [53]. It has been
demonstrated that mitochondrial rRNAs can outnumber mitochondrial mRNAs coding for
elements of oxidative phosphorylation complexes by a factor of 30 [54]. Therefore, even a
small decrease in expression of ribosomal genes should result in substantially increased expres-
sion of the oxidative phosphorylation genes. In sum, the postulate that genetic robustness
depends critically on the ability to generate metabolic energy through oxidative phosphoryla-
tion appears to be well founded, both in terms of statistical results and functional interpreta-
tion of our data.
Subsequent experiments supported our hypothesis. A simple test of growth on glucose and
ethanol showed, that not proficiency in fermentation but in respiration correlated with genetic
robustness (Fig 6). Both fermentation and respiration are used to generate ATP when glucose
Genetic robustness in yeast
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is relatively low and growth is slow. Respiration actually dominates under these conditions in
the G1 phase when most of biosynthesis, and thus growth, is accomplished [55, 56]. The two
other tests were based on experimental manipulation. They showed that growth rates of
mutants decreased when the electron transport chain was inhibited chemically, and increased
when one of its elements, cytochrome c, was overexpressed. Sodium azide is well known and
often used as a specific inhibitor of the electron transport chain [57]. There is no comparably
easy way to boost respiration. The electron transport chain is composed of several protein
complexes. The only element that is critical for the chain and formed from a single polypeptide
is cytochrome c, which was the reason why we chose to overexpress this particular protein.
But, cytochrome c cooperates with two large complexes in transporting electrons, its reductase
and oxidase, and requires assistance from several proteins to mature and end up in the inter-
membrane matrix of the mitochondrion. These proteins were not overproduced. We consider
it remarkable that we nevertheless observed a significantly positive effect on fitness in most
mutant clones. Some mutants appeared to suffer, but it is possible that supplying more energy
to improper functions, such as altered signalling or transportation, can be harmful. In sum,
the combined growth rate data obtained in this study, the expression data from a former study
of the same strains [34] and literature on yeast metabolism, support the conclusion that the
genetic robustness of yeast cells is critically dependent on the availability of energy. This result
accords with a recent finding that the ability to generate additional ATPs through even a
minor redirection of the carbon flux from fermentation towards respiration helps to amelio-
rate negative effects of production of unnecessary proteins [58].
There was no indication of a positive correlation between genetic robustness and high
expression of molecular chaperones or other proteins that could potentially enhance genetic
robustness. The GO classification contains both general and narrow categories of molecular
chaperones, but none of them showed up as enriched, even if liberal criteria of statistical signif-
icance were applied. It is possible that refolding of destabilized proteins is most important
under environmental stress. In our experiment, environmental stress was absent and proteins
destabilized by mutations may have been too rare to incite a protective activity of chaperones
[59–63]. Moreover, the expectation that chaperones typically buffer negative effects of muta-
tions may not be universally true. We have postulated that the Hsp70 chaperones can rather
help to dispose destabilized proteins instead of assisting their refolding. However, such pro-
teins could be then at too low levels to fulfill their functions and therefore their negative effects
would be increased [28, 29]. A recent study has demonstrated that the Hsp90 chaperone does
act as a buffer for the effects of standing genetic variation, but it actually increases the effects of
new random mutations [64]. A GO analysis should not be taken as evidence that certain gene
categories, such as chaperones, are not important for the studied trait, because the method is
effective in detecting only sufficiently strong positive signals. Nevertheless, we suggest that
great care is needed when considering the role of molecular chaperone in masking of muta-
tional damage.
The main conclusion emerging from our study is that genetic robustness partly rests on
metabolic vigor. It implies that robustness can be aided by any feature of an organism helping
its metabolism to function under the given environmental conditions. The efficiency of energy
metabolism is probably one of general agents of robustness. It is possibly less critical when, for
example, resources are abundant and growth depends mostly on the capabilities of assembling
large numbers of ribosomes and sustaining their efficient functioning, which appear to be
more challenging in terms of maintaining structures than securing energy [49, 65]. However,
most microbial cells in the wild grow slowly or do not grow at all [66]. Effective energy metab-
olism is likely crucial under such circumstances, and especially so when some elements of the
cell are damaged by mutations. Indeed, wild yeast strains bear sizable amounts of mutations,
Genetic robustness in yeast
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suggesting that natural selection is typically not effective enough to purge them [37]. The more
complex systems are the more likely imperfections to occur. Over long time intervals, the abil-
ity to generate sufficient levels of energy could be the main force driving the evolution of
eukaryotes, that is, making organisms complex, evolvable and robust [67].
Materials and methods
Strains and plasmids
A collection of yeast isolates originating from the wild and human-associated environments
[33] has been converted into a set of strains that were stably haploid, auxotrophic for uracil
and resistant to hygromycin B and geneticin, ho::hphMX4 ura3::kanMX4 [41]. From those, we
used a subset of S. cerevisiae haploid strains in our former study [39]. These, and their MATα
counterparts, were selected also for the present experiment, except for L-1528, DBVPG6044
and NCYC10, as they were not included into a study of gene expression which provided data
used for our Gene Ontology analyses [34]. Except of being included in that study, there were
some other constrains for strain selection. One was the suitability for reliable measurements of
the maximum growth rate. The measurements had to be carried out in conditions similar to
those used in a study in which data on gene expression had been collected [34]. UWOPS83-
787.3 YPS 606 and SK1were dropped due to poor/undetectable growth or intense cell aggrega-
tion in the MGR assays described below. Another test of suitability was the assay or uracil proto/
auxotrophy. A functional allele of the URA3gene derived from Candida albicans, inserted within
the MX4 cassette on pAG60 plasmid, was used as a replacement for either kan4MX4 or hphMX4
residing on chromosomes. For each strain, MATα URA3 and MATa URA3 strains with alterna-
tive resistance markers left were obtained using PEG/LiAc transformation protocol [68]. Strain
UWOPS03_227.2 was discarded because it typically yielded only a few colonies on the 5-FOA
medium independent of the dose of EMS applied in the mutagenesis. As a result, 15 strains per-
formed satisfactorily in both the 5-FOA and the maximum growth rate assays which permitted
their use in the subsequent experiments. The final list of strains used in the mutagenesis and
assays of genetic robustness comprises: L_1374, DBVPG1106, DBVPG1373, YJM975, YJM978,
YJM981, DBVPG6765, BC187, 273614, YPS128, Y12, UWOPS87_2421, UWOPS05_227_2,
UWOPS05_217_3, Y55.
In experiments following the assays of robustness we used BY4742 MATα, and two plas-
mids: pKATO1 HIS3 leu2d PTEF-CYC1 (pCYC1) and pKATO2 HIS3 leu2d PGAL1-URA3-YFP
(pControl). Both plasmids were derived from pRS425 (NCBI gi:416323). In all tests, plasmids
were stabilized by omitting histidine in growth media which results in a relatively low number
of plasmids per cell [69]. Galactose was never used and therefore expression of the fusion pro-
tein from the pControl plasmid was absent.
EMS mutagenesis
Aliquots of 15 ml of stationary phase cultures, grown in SC-uracil at 30˚C with 250 rpm shak-
ing, were prepared for every strain and mating type. These were then equalized to OD = 1.2
and dispensed into microcentrifuge tubes, 1 ml per tube. Cells were centrifuged and the pellets
were washed with 1 ml of potassium phosphate buffer (pH = 7) and then re-suspended in it.
EMS was dispensed to set up a gradient of 0, 2, 5, 10, 15, 20, 25, 30, 40 and 60 μl/ml. (Not all of
those concentrations were used in particular phenotypic assays, e.g. the highest EMS dose
turned out to be too severe and was discarded). The mixtures were incubated for 1 hour at
30˚C with periodic vortexing. They were then spun down, supernatant was decanted and sam-
ples were washed with 10% sodium thiosulfate (Na2S2O3), re-suspended in 1ml of water and
left overnight at 4˚C. The treated cells were then transferred to new growth medium and the
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new cultures were allowed to reach the stationary phase again. This allowed to complete sev-
eral divisions and therefore fix the effects of EMS treatment. These new cultures were used to
initiate screens with 5-FOA for Ura¯ phenotype.
Cell mortality
To test the effects of EMS on survival, 0.1 ml samples of the overnight cultures (kept at 4˚C,
see above) were serially diluted and grown at 30˚C for 2 or 3 days on YPD agar plates. The
plates were then photographed and colonies were counted with OpenCFU software [70] or
manually, if necessary. The obtained counts were used to plot survival curves and calculate the
LD50 Δ with the drm function of the drc package in R.
Mutant frequency
The remaining portions of the overnight 4˚C cultures were transferred to 10 ml YPD and incu-
bated at 30˚C for 3 days. OD was measured (TECAN) and equalized to 1.6. Samples of the
resulting cultures were plated onto synthetic complete plates supplemented with 0.1% of
5-FOA. After 3–4 days of incubation at 30˚C, colonies were counted manually.
Growth rate
The ‘cell mortality’ assay yielded colonies that developed from mutagenized cells on YPD
plates. These colonies were selected at random and streaked to single cells to ensure that colo-
nies derived this way were clonal. In sum, a total of 112 post-mutagenesis colonies of every
strain (8 clones per every mating type, per 7 EMS doses: 0, 2, 5, 10, 20, 30,40 μl/ml) were was
drawn at random, and after streaking to singles, one clone was derived for each of them. The
resulting clones were grown individually as 200 μl micro-cultures in flat-bottom titration
plates in order to measure MGR. The medium used in this assay was synthetic with low carbon
(5 g/l of glucose) and limiting phosphorous levels (10 μg/l of sodium phosphate monobasic
anhydrous—USP), as described previously [34].
Number of phenotypic effects
The Bateman-Mukai formulae were used to estimate the number of negative growth effects for
each strain [48]. The maximum average effect of a mutation is: a = ΔV / 2ΔM, the minimum
number of effects is U = 2(ΔM)2 / ΔV, where ΔM is a decrease in the average MGR and ΔV is
an increase in the variance of MGR. Averages (Ms) and variances (Vs) were calculated for 16
replicate clones per strain per EMS dose (the two mating types were polled as there was no sta-
tistical difference between them).
Spectrophotometric analysis of the cytochrome c
Cultures were grown under conditions used in the assay of genetic robustness. Intact cells
were harvested at the exponential growth phase, cooled, condensed to form 1 mm thick paste,
and immersed in liquid nitrogen prior to measurement [71, 72].
Supporting information
S1 Table. Data referring to statistical analyses and graphs as identified by names of conse-
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